<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hernandez-Arciga U</submitter><funding>NIA NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>eads1532</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12002124</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(16)</volume><pubmed_abstract>Aging is associated with dysregulated methionine metabolism and increased levels of enzymes in the tyrosine degradation pathway (TDP). To investigate the efficacy of targeting either methionine metabolism or the TDP for healthspan improvement in advanced age, we initiated dietary MetR or TDP inhibition in 18-month-old C57BL/6J mice. MetR significantly improved neuromuscular function, metabolic health, lung function, and frailty. In addition, we confirmed improved neuromuscular function from dietary MetR in 5XFAD mice, whose weight was not affected by MetR. We did not observe benefits with TDP inhibition. Single-nucleus RNA and ATAC sequencing of muscle revealed cell type-specific responses to MetR, although MetR did not significantly affect mouse aging epigenetic clock markers. Similarly, </pubmed_abstract><journal>Science advances</journal><pubmed_title>Dietary methionine restriction started late in life promotes healthy aging in a sex-specific manner.</pubmed_title><pmcid>PMC12002124</pmcid><funding_grant_id>P30 AG013319</funding_grant_id><funding_grant_id>R35 GM146869</funding_grant_id><funding_grant_id>U54 AG075931</funding_grant_id><funding_grant_id>R01 AG070034</funding_grant_id><funding_grant_id>P30 AG024827</funding_grant_id><funding_grant_id>K01 DK115543</funding_grant_id><funding_grant_id>R01 HL135062</funding_grant_id><funding_grant_id>R03 AG075651</funding_grant_id><funding_grant_id>S10 OD023684</funding_grant_id><funding_grant_id>P30 AG068635</funding_grant_id><funding_grant_id>R01 DK138967</funding_grant_id><funding_grant_id>U54 AG054345</funding_grant_id><funding_grant_id>R00 AG057792</funding_grant_id><funding_grant_id>R01 AG082696</funding_grant_id><funding_grant_id>R21 DK121266</funding_grant_id><pubmed_authors>Vinknes KJ</pubmed_authors><pubmed_authors>Brooke RT</pubmed_authors><pubmed_authors>Elshorbagy A</pubmed_authors><pubmed_authors>Molina E</pubmed_authors><pubmed_authors>Weisz OA</pubmed_authors><pubmed_authors>Stamenkovic C</pubmed_authors><pubmed_authors>Bueno M</pubmed_authors><pubmed_authors>Chuan B</pubmed_authors><pubmed_authors>Albalawy WN</pubmed_authors><pubmed_authors>Ovrebo B</pubmed_authors><pubmed_authors>Alder JK</pubmed_authors><pubmed_authors>Sacco A</pubmed_authors><pubmed_authors>Al Hammood F</pubmed_authors><pubmed_authors>Pinto AFM</pubmed_authors><pubmed_authors>Pascal LE</pubmed_authors><pubmed_authors>Gonzalez TF</pubmed_authors><pubmed_authors>Flores LC</pubmed_authors><pubmed_authors>Tan RJ</pubmed_authors><pubmed_authors>Graham A</pubmed_authors><pubmed_authors>Cooke D</pubmed_authors><pubmed_authors>Parkhitko AA</pubmed_authors><pubmed_authors>Sukoff Rizzo SJ</pubmed_authors><pubmed_authors>Yadav S</pubmed_authors><pubmed_authors>Williams SG</pubmed_authors><pubmed_authors>Sipula IJ</pubmed_authors><pubmed_authors>Hartman HL</pubmed_authors><pubmed_authors>Stolt E</pubmed_authors><pubmed_authors>Eickelberg O</pubmed_authors><pubmed_authors>Ikeno Y</pubmed_authors><pubmed_authors>Hernandez-Arciga U</pubmed_authors><pubmed_authors>Steinhauser ML</pubmed_authors><pubmed_authors>McMahon B</pubmed_authors><pubmed_authors>Troensegaard H</pubmed_authors><pubmed_authors>Smarz C</pubmed_authors><pubmed_authors>Olsen T</pubmed_authors><pubmed_authors>Naikwadi MU</pubmed_authors><pubmed_authors>Diedrich JK</pubmed_authors><pubmed_authors>Ables GP</pubmed_authors><pubmed_authors>Jurczak MJ</pubmed_authors><pubmed_authors>Finkel T</pubmed_authors><pubmed_authors>Vandevender AM</pubmed_authors><pubmed_authors>Nicoletti C</pubmed_authors><pubmed_authors>Frahm KA</pubmed_authors><pubmed_authors>Little GJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dietary methionine restriction started late in life promotes healthy aging in a sex-specific manner.</name><description>Aging is associated with dysregulated methionine metabolism and increased levels of enzymes in the tyrosine degradation pathway (TDP). To investigate the efficacy of targeting either methionine metabolism or the TDP for healthspan improvement in advanced age, we initiated dietary MetR or TDP inhibition in 18-month-old C57BL/6J mice. MetR significantly improved neuromuscular function, metabolic health, lung function, and frailty. In addition, we confirmed improved neuromuscular function from dietary MetR in 5XFAD mice, whose weight was not affected by MetR. We did not observe benefits with TDP inhibition. Single-nucleus RNA and ATAC sequencing of muscle revealed cell type-specific responses to MetR, although MetR did not significantly affect mouse aging epigenetic clock markers. Similarly, </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-01T10:20:26.857Z</modification><creation>2026-04-08T11:18:57.388Z</creation></dates><accession>S-EPMC12002124</accession><cross_references><pubmed>40238871</pubmed><doi>10.1126/sciadv.ads1532</doi></cross_references></HashMap>